These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 12650956)

  • 1. SSRIs antidepressant activity is influenced by G beta 3 variants.
    Serretti A; Lorenzi C; Cusin C; Zanardi R; Lattuada E; Rossini D; Lilli R; Pirovano A; Catalano M; Smeraldi E
    Eur Neuropsychopharmacol; 2003 Mar; 13(2):117-22. PubMed ID: 12650956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antidepressant response and intolerance to SSRI is not influenced by G-protein beta3 subunit gene C825T polymorphism in Japanese major depressive patients.
    Kato M; Wakeno M; Okugawa G; Fukuda T; Takekita Y; Hosoi Y; Azuma J; Kinoshita T; Serretti A
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 May; 32(4):1041-4. PubMed ID: 18325652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of tryptophan hydroxylase and serotonin transporter genes on fluvoxamine antidepressant activity.
    Serretti A; Zanardi R; Rossini D; Cusin C; Lilli R; Smeraldi E
    Mol Psychiatry; 2001 Sep; 6(5):586-92. PubMed ID: 11526473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of monoamine oxidase A and serotonin receptor 2A polymorphisms in SSRI antidepressant activity.
    Cusin C; Serretti A; Zanardi R; Lattuada E; Rossini D; Lilli R; Lorenzi C; Smeraldi E
    Int J Neuropsychopharmacol; 2002 Mar; 5(1):27-35. PubMed ID: 12057029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors affecting fluvoxamine antidepressant activity: influence of pindolol and 5-HTTLPR in delusional and nondelusional depression.
    Zanardi R; Serretti A; Rossini D; Franchini L; Cusin C; Lattuada E; Dotoli D; Smeraldi E
    Biol Psychiatry; 2001 Sep; 50(5):323-30. PubMed ID: 11543734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-HT2A gene variants influence specific and different aspects of antidepressant response in Japanese and Italian mood disorder patients.
    Kato M; Zanardi R; Rossini D; De Ronchi D; Okugawa G; Kinoshita T; Colombo C; Serretti A
    Psychiatry Res; 2009 May; 167(1-2):97-105. PubMed ID: 19361869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Further evidence of a combined effect of SERTPR and TPH on SSRIs response in mood disorders.
    Serretti A; Cusin C; Rossini D; Artioli P; Dotoli D; Zanardi R
    Am J Med Genet B Neuropsychiatr Genet; 2004 Aug; 129B(1):36-40. PubMed ID: 15274037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response to sertraline is influenced by GNβ3 gene G-350A variant in patients with major depressive disorder.
    Firouzabadi D; Firouzabadi N; Kalani K; Zomorrodian K; Tehrani ES
    Eur J Clin Pharmacol; 2019 Feb; 75(2):189-194. PubMed ID: 30324302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine.
    Smeraldi E; Zanardi R; Benedetti F; Di Bella D; Perez J; Catalano M
    Mol Psychiatry; 1998 Nov; 3(6):508-11. PubMed ID: 9857976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tryptophan hydroxylase gene associated with paroxetine antidepressant activity.
    Serretti A; Zanardi R; Cusin C; Rossini D; Lorenzi C; Smeraldi E
    Eur Neuropsychopharmacol; 2001 Oct; 11(5):375-80. PubMed ID: 11597824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 40-basepair VNTR polymorphism in the dopamine transporter (DAT1) gene and the rapid response to antidepressant treatment.
    Kirchheiner J; Nickchen K; Sasse J; Bauer M; Roots I; Brockmöller J
    Pharmacogenomics J; 2007 Feb; 7(1):48-55. PubMed ID: 16702979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How long should pindolol be associated with paroxetine to improve the antidepressant response?
    Zanardi R; Artigas F; Franchini L; Sforzini L; Gasperini M; Smeraldi E; Perez J
    J Clin Psychopharmacol; 1997 Dec; 17(6):446-50. PubMed ID: 9408806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind, randomized, placebo-controlled trial of pindolol augmentation in depressive patients resistant to serotonin reuptake inhibitors. Grup de Recerca en Trastorns Afectius.
    Pérez V; Soler J; Puigdemont D; Alvarez E; Artigas F
    Arch Gen Psychiatry; 1999 Apr; 56(4):375-9. PubMed ID: 10197835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No association between dopamine D(2) and D(4) receptor gene variants and antidepressant activity of two selective serotonin reuptake inhibitors.
    Serretti A; Zanardi R; Cusin C; Rossini D; Lilli R; Lorenzi C; Lattuada E; Smeraldi E
    Psychiatry Res; 2001 Nov; 104(3):195-203. PubMed ID: 11728608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective activation of postsynaptic 5-HT1A receptors induces rapid antidepressant response.
    Blier P; Bergeron R; de Montigny C
    Neuropsychopharmacology; 1997 May; 16(5):333-8. PubMed ID: 9109104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic variation in GRIK4 and the implications for antidepressant treatment.
    Paddock S
    Pharmacogenomics; 2008 Feb; 9(2):133-5. PubMed ID: 18370842
    [No Abstract]   [Full Text] [Related]  

  • 17. [Use of antidepressant drugs in schizophrenic patients with depression].
    Micallef J; Fakra E; Blin O
    Encephale; 2006; 32(2 Pt 1):263-9. PubMed ID: 16910628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An index of 5-HT synthesis changes during early antidepressant treatment: alpha-[11C]methyl-L-tryptophan PET study.
    Berney A; Nishikawa M; Benkelfat C; Debonnel G; Gobbi G; Diksic M
    Neurochem Int; 2008; 52(4-5):701-8. PubMed ID: 17928105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for an association between a G-protein beta3-gene variant with depression and response to antidepressant treatment.
    Zill P; Baghai TC; Zwanzger P; Schüle C; Minov C; Riedel M; Neumeier K; Rupprecht R; Bondy B
    Neuroreport; 2000 Jun; 11(9):1893-7. PubMed ID: 10884039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allelic variation in the serotonin transporter promoter affects onset of paroxetine treatment response in late-life depression.
    Pollock BG; Ferrell RE; Mulsant BH; Mazumdar S; Miller M; Sweet RA; Davis S; Kirshner MA; Houck PR; Stack JA; Reynolds CF; Kupfer DJ
    Neuropsychopharmacology; 2000 Nov; 23(5):587-90. PubMed ID: 11027924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.